BioSpace News Archive

Press Releases

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong sales growth momentum of 7% (CER) in the first nine months of 2025; full-year earnings outlook raised

October 23, 2025
·
25 min read
Press Releases

Harbour BioMed Announces Positive Phase II Results for HBM4003 and Tislelizumab Combination in MSS mCRC

October 23, 2025
·
4 min read
Press Releases

Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey

October 23, 2025
·
3 min read
Press Releases

Alligator Bioscience AB Reports Financial Results for Q3 2025 and Provides a Business Update

October 23, 2025
·
4 min read
Press Releases

Changes to the Roche Enlarged Corporate Executive Committee - October 23, 2025

October 23, 2025
·
2 min read
Press Releases

Interim Report January-September 2025

October 23, 2025
·
5 min read
Press Releases

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

October 23, 2025
·
1 min read
Press Releases

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

October 23, 2025
·
2 min read
Press Releases

IRLAB: Invitation To The Interim Report For Q3 2025 Presentation And Webcast

October 23, 2025
·
1 min read
Press Releases

FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each in Combination with Padcev® (enfortumab vedotin-ejfv), for Certain Patients with Muscle-Invasive Bladder Cancer

October 23, 2025
·
19 min read